Monday, 29 June 2026

The history of the Pyrido[1,2-a]pyrimidin-4-one

 


The history of the pyrido[1,2-a]pyrimidin-4-one. The forty years error and the correction byDr. Hekmat B Antaki (1923–1992)



The structure of the parent pyrido[1,2-a]pyrimidin-4-one ring system was settled by H. Antaki and V. Petrow in 1951, was characterized via ultraviolet spectroscopy from 1958–1962, and became the active core of globally marketed therapeutics.

The Question and the Era

This article reconstructs, from original documents, an obscure but highly consequential sequence in the history of a valuable chemical scaffold. The purpose is to preserve a precise account: what was corrected, how the correction was proved, how the work expanded into a general chemistry of condensed pyrimidines, and where that chemistry stands today.

The events belong to a period of structural chemistry now difficult to reconstruct without bias. Questions that are approached today by routinely combining NMR, mass spectrometry, crystallography, and computation had to be answered purely by chemical behavior, degradation, analogy, electronic reasoning, and independent synthesis. To evaluate the complexity of the problem fairly, one must look through the lens of the instruments and conceptual frameworks available to those who faced it at the time.

The achievement was finding the reasoning by which the structure could be understood within the constraints of the era. The question is how Antaki identified the decisive structural uncertainty and devised a way to resolve it under the conditions of 1950.


The Road (1950)

The compound at the center of the question had been prepared early in the century, and by 1950 its structure had been approached and re-approached for nearly four decades. In his doctoral thesis, Contributions to the Chemistry of Heterocyclic Compounds (University of London, 1950), Hekmat Antaki set out that long history in full—giving each earlier worker their due.

A significant, overlooked aspect of this period was a deep-seated error in the existing literature regarding how pyridine derivatives condensed with aromatic acids. Early pioneers Reissert (1895) and Räth (1931) had confidently claimed that these reactions yielded 1,8-naphthyridine architectures (specifically, 2,3-benzo-4-hydroxy-1,8-naphthyridine). Räth had even attempted to validate this via an alkaline oxidation that yielded what he identified as "2-aminonicotinic acid," melting at 217°C—far below the true 310°C standard reported by Philips for the authentic compound.

Antaki's work confirmed that these products were actually 2,3-benzo-4-keto-1-aza-4-quinolizines. While oxidative degradation established the broader skeleton, it remained fundamentally blind to the finer question: the precise position of the carbonyl group within that skeleton.

As mapped in the original thesis records in IMG_5449_2.jpg, Antaki systematically charted the temperature-dependent pathways of 2-aminopyridine and ethyl acetoacetate to isolate the precise conditions under which intermediate compounds transitioned into the final base.

What the thesis added was an elegant explanation of why the ring formed as it did, leveraging structural electronic theory to clear up decades of confusion. The closure to one skeleton rather than its isomer, Antaki argued, received a ready explanation on the basis of chemical physics:

“The electronegativity of the nitrogen atom is known to be greater than that of carbon. An electron-releasing group at the appropriate position leads to an increase in the electron density on the nuclear nitrogen. Prototropic rearrangement follows,” directing the closure to the observed product.

Because the high electronegativity of the nuclear nitrogen in 2-aminopyridine increases electron density, it drives an electrophilic attack straight to the nuclear nitrogen rather than the carbon backbone. This was an argument from basic electronic principles—the reasoning of a chemist who understood the system from its core physics, not merely its raw products.

To view the full chemistry formulas, data, and complete research paper, please view the full article on https://hekmatantaki.org/.

The Antaki Synthesis

Three-component condensation for hexahydroquinoline formation — first reported by H. Antaki, Research Institute for Tropical Medicine, Cairo, 1963

The Synthesis

To view the full chemistry formulas, data, and complete research paper, please view the full article on https://hekmatantaki.org/.

Structural Correction II: The Steroid Series

 


The Steroids structural correction Dr. Hekmat B Antaki (1923–1992)



Antaki reassigned the structure from the angular [2′:3′-3:4] to the linear [2′:3′-3:2] cholestane. The revised assignment corrected a structure co-authored by V. Petrow, Antaki's collaborator and co-author on the published paper.


In Part II of his doctoral thesis (Queen Mary College, University of London, 1950, pp. 91–94), Antaki re-examined the indolo-cholestane that Dorée and Petrow had formulated as the angular isomer in 1935. The angular assignment had rested on surface-film measurements that were themselves inconclusive. Working from the established chemistry of the cholestanones, Antaki reassigned the structure from the angular [2′:3′-3:4] to the linear [2′:3′-3:2] cholestane. The revised assignment corrected a structure co-authored by V. Petrow, Antaki's collaborator and co-author on the published paper.

The full argument was set out in the thesis and published in compressed form in Part XII of the steroid work (J. Chem. Soc., 1951, 901). The reassignment was confirmed experimentally by Y. Ban and Y. Sato (Chem. Pharm. Bull., 1965, 13, 1073), who established the linear structure by ozonolytic degradation, carrying it through to the known Windaus–Uibrig acid. B. Robinson's review of the Fischer indole synthesis (Chem. Rev., 1969) records the same citation.

To view the full chemistry formulas, data, and complete research paper, please view the full article on https://hekmatantaki.org/.

Friday, 13 May 2011

Just some photos South America 2011


The Monkey Orchid


The Dracula Orchid